From Anecdotal Knowledge to Evidence Based: The Future of Cannabis Research
(Opening Keynote) Recently, the therapeutic potential of phytocannabinoids, the unique active compounds of the cannabis plant, has been rediscovered for many types of illness. More than 120 phytocannabinoids have been identified within the cannabis plant making this plant complicated and difficult to predict specific clinical effects of cannabis treatment in a patient.
Our lab investigates the therapeutic potential of phytocannabinoids when on-top on other studies conducting in the lab, the main focus is on cancer, epilepsy and glucose metabolism (diabetes). These studies relay on our abilities to characterize all the cannabis components.
In Addition to ‘basic science’, our lab collaborates with cannabis growers, clinicians and major manufacturers and distributors of medical cannabis. In this work, we are creating the “medical cannabis database” which together with a simultaneous laboratory research and clinical trials, aim to provide physicians with the necessary information to enable them to reach evidence based decisions when prescribing cannabis treatment.